ATC Group: A01AB04 Amphotericin B

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A01AB04 in the ATC hierarchy

Level
Code
Title
1
Alimentary tract and metabolism
2
Stomatological preparations
3
Stomatological preparations
4
Antiinfectives and antiseptics for local oral treatment
5
A01AB04
Amphotericin B

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route
Amount
ORAL - Oral
40 mg

Active ingredients in A01AB04

Active Ingredient
Description

Amphotericin B is a macrocyclic, polyene antifungal antibiotic produced by Streptomyces nodosus. The molecule is thought to act by binding to sterols in the fungal cell membrane, with a resulting change in membrane permeability, allowing leakage of a variety of small molecules.

Medicines in this ATC group

Drug
Countries

Australia New Zealand

Canada Estonia Finland France Hong Kong ...